Article
作者: Andreucci, Elena ; Mroweh, Nabil ; Trisciuoglio, Daniela ; Peppicelli, Silvia ; Giuliani, Lidia ; Calorini, Lido ; Biagioni, Alessio ; Supuran, Claudiu T. ; Valente, Sergio ; Mai, Antonello ; Astolfi, Roberta ; Ragno, Rino ; Angeli, Andrea ; Bozdag, Murat ; Raucci, Alessia ; Zwergel, Clemens ; Carta, Fabrizio
This study reports in vitro evidence supporting a new class of compounds capable of independently targeting the tumor-associated human (h) carbonic anhydrase (CA; EC 4.2.1.1) and histone deacetylase (HDAC; EC 3.5.1.98) isoforms as first-in-class agents endowed with enhanced antiproliferative effects and safety profiles when compared to their constitutive counterparts as well as to clinically used drugs. The binding modes of both the CA- and HDAC-directed moieties were investigated through X-ray and molecular modeling experiments, respectively, thus delivering detailed Structure-Activity Relationship (SAR) knowledge.